142 related articles for article (PubMed ID: 15272206)
1. Validation of a [3H]astemizole binding assay in HEK293 cells expressing HERG K+ channels.
Chiu PJ; Marcoe KF; Bounds SE; Lin CH; Feng JJ; Lin A; Cheng FC; Crumb WJ; Mitchell R
J Pharmacol Sci; 2004 Jul; 95(3):311-9. PubMed ID: 15272206
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of depolarization-induced [3H]noradrenaline release from SH-SY5Y human neuroblastoma cells by some second-generation H(1) receptor antagonists through blockade of store-operated Ca(2+) channels (SOCs).
Taglialatela M; Secondo A; Fresi A; Rosati B; Pannaccione A; Castaldo P; Giorgio G; Wanke E; Annunziato L
Biochem Pharmacol; 2001 Nov; 62(9):1229-38. PubMed ID: 11705456
[TBL] [Abstract][Full Text] [Related]
3. The [3H]dofetilide binding assay is a predictive screening tool for hERG blockade and proarrhythmia: Comparison of intact cell and membrane preparations and effects of altering [K+]o.
Diaz GJ; Daniell K; Leitza ST; Martin RL; Su Z; McDermott JS; Cox BF; Gintant GA
J Pharmacol Toxicol Methods; 2004; 50(3):187-99. PubMed ID: 15519905
[TBL] [Abstract][Full Text] [Related]
4. Block of HERG potassium channels by the antihistamine astemizole and its metabolites desmethylastemizole and norastemizole.
Zhou Z; Vorperian VR; Gong Q; Zhang S; January CT
J Cardiovasc Electrophysiol; 1999 Jun; 10(6):836-43. PubMed ID: 10376921
[TBL] [Abstract][Full Text] [Related]
5. Blockade of HERG channels expressed in Xenopus oocytes by the histamine receptor antagonists terfenadine and astemizole.
Suessbrich H; Waldegger S; Lang F; Busch AE
FEBS Lett; 1996 Apr; 385(1-2):77-80. PubMed ID: 8641472
[TBL] [Abstract][Full Text] [Related]
6. [3H]dofetilide binding in SHSY5Y and HEK293 cells expressing a HERG-like K+ channel?
Finlayson K; Pennington AJ; Kelly JS
Eur J Pharmacol; 2001 Feb; 412(3):203-12. PubMed ID: 11166283
[TBL] [Abstract][Full Text] [Related]
7. [3H]dofetilide binding to HERG transfected membranes: a potential high throughput preclinical screen.
Finlayson K; Turnbull L; January CT; Sharkey J; Kelly JS
Eur J Pharmacol; 2001 Oct; 430(1):147-8. PubMed ID: 11698075
[TBL] [Abstract][Full Text] [Related]
8. A mechanism for the proarrhythmic effects of cisapride (Propulsid): high affinity blockade of the human cardiac potassium channel HERG.
Rampe D; Roy ML; Dennis A; Brown AM
FEBS Lett; 1997 Nov; 417(1):28-32. PubMed ID: 9395068
[TBL] [Abstract][Full Text] [Related]
9. Epinastine, a nonsedating histamine H1 receptor antagonist, has a negligible effect on HERG channel.
Chachin M; Katayama Y; Yamada M; Horio Y; Ohmura T; Kitagawa H; Uchida S; Kurachi Y
Eur J Pharmacol; 1999 Jun; 374(3):457-60. PubMed ID: 10422790
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological separation of hEAG and hERG K+ channel function in the human mammary carcinoma cell line MCF-7.
Roy J; Vantol B; Cowley EA; Blay J; Linsdell P
Oncol Rep; 2008 Jun; 19(6):1511-6. PubMed ID: 18497958
[TBL] [Abstract][Full Text] [Related]
11. Allosteric modulators of the hERG K(+) channel: radioligand binding assays reveal allosteric characteristics of dofetilide analogs.
Yu Z; Klaasse E; Heitman LH; Ijzerman AP
Toxicol Appl Pharmacol; 2014 Jan; 274(1):78-86. PubMed ID: 24200993
[TBL] [Abstract][Full Text] [Related]
12. Blockage of the HERG human cardiac K+ channel by the gastrointestinal prokinetic agent cisapride.
Mohammad S; Zhou Z; Gong Q; January CT
Am J Physiol; 1997 Nov; 273(5):H2534-8. PubMed ID: 9374794
[TBL] [Abstract][Full Text] [Related]
13. Redox state dependency of HERGS631C channel pharmacology: relation to C-type inactivation.
Ulens C; Tytgat J
FEBS Lett; 2000 May; 474(1):111-5. PubMed ID: 10828461
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of functional and binding assays in cells expressing either recombinant or endogenous hERG channel.
Murphy SM; Palmer M; Poole MF; Padegimas L; Hunady K; Danzig J; Gill S; Gill R; Ting A; Sherf B; Brunden K; Stricker-Krongrad A
J Pharmacol Toxicol Methods; 2006; 54(1):42-55. PubMed ID: 16326118
[TBL] [Abstract][Full Text] [Related]
15. Molecular determinants of dofetilide block of HERG K+ channels.
Ficker E; Jarolimek W; Kiehn J; Baumann A; Brown AM
Circ Res; 1998 Feb; 82(3):386-95. PubMed ID: 9486667
[TBL] [Abstract][Full Text] [Related]
16. Estimation of potency of HERG channel blockers: impact of voltage protocol and temperature.
Yao JA; Du X; Lu D; Baker RL; Daharsh E; Atterson P
J Pharmacol Toxicol Methods; 2005; 52(1):146-53. PubMed ID: 15936218
[TBL] [Abstract][Full Text] [Related]
17. Cryo-EM Structure of K
Asai T; Adachi N; Moriya T; Oki H; Maru T; Kawasaki M; Suzuki K; Chen S; Ishii R; Yonemori K; Igaki S; Yasuda S; Ogasawara S; Senda T; Murata T
Structure; 2021 Mar; 29(3):203-212.e4. PubMed ID: 33450182
[TBL] [Abstract][Full Text] [Related]
18. An aqueous extract of Poncirus fructus activates the prokinetic activity of 5-HT receptor subtype 4 without hERG interaction.
Shim WS; Back H; Jung SW; Kim JW; Jang Y; Lee B; Seo EK; Oh U; Shim CK
J Ethnopharmacol; 2010 Oct; 132(1):328-33. PubMed ID: 20736054
[TBL] [Abstract][Full Text] [Related]
19. Intracellular K+ is required for the inactivation-induced high-affinity binding of cisapride to HERG channels.
Lin J; Guo J; Gang H; Wojciechowski P; Wigle JT; Zhang S
Mol Pharmacol; 2005 Sep; 68(3):855-65. PubMed ID: 15967876
[TBL] [Abstract][Full Text] [Related]
20. Block of wild-type and inactivation-deficient human ether-a-go-go-related gene K+ channels by halofantrine.
Sánchez-Chapula JA; Navarro-Polanco RA; Sanguinetti MC
Naunyn Schmiedebergs Arch Pharmacol; 2004 Dec; 370(6):484-91. PubMed ID: 15558243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
